Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0151744 (
myocardial ischemia
)
31,282
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cripto-1
is a membrane-bound protein that is highly expressed in embryonic stem cells and in human tumors. In the present study, we investigated the effect of low levels of oxygen, which occurs naturally in rapidly growing tissues, on
Cripto-1
expression in mouse embryonic stem (mES) cells and in human embryonal carcinoma cells. During hypoxia,
Cripto-1
expression levels were significantly elevated in mES cells and in Ntera-2 or NCCIT human embryonal carcinoma cells, as compared with cells growing with normal oxygen levels. The transcription factor hypoxia-inducible factor-1alpha directly regulated
Cripto-1
expression by binding to hypoxia-responsive elements within the promoter of mouse and human
Cripto-1
genes in mES and NCCIT cells, respectively. Furthermore, hypoxia modulated differentiation of mES cells by enhancing formation of beating cardiomyocytes as compared with mES cells that were differentiated under normoxia. However, hypoxia failed to induce differentiation of mES cells into cardiomyocytes in the absence of
Cripto-1
expression, demonstrating that
Cripto-1
is required for hypoxia to fully differentiate mES cells into cardiomyocytes. Finally, cardiac tissue samples derived from patients who had suffered
ischemic heart disease
showed a dramatic increase in
Cripto-1
expression as compared with nonischemic heart tissue samples, suggesting that hypoxia may also regulate
Cripto-1
in vivo.
...
PMID:Cripto-1 is required for hypoxia to induce cardiac differentiation of mouse embryonic stem cells. 1983 60